These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
467 related articles for article (PubMed ID: 25286385)
1. Neuroinflammation in Alzheimer's disease; A source of heterogeneity and target for personalized therapy. Latta CH; Brothers HM; Wilcock DM Neuroscience; 2015 Aug; 302():103-11. PubMed ID: 25286385 [TBL] [Abstract][Full Text] [Related]
2. Neuroinflammation in Alzheimer's disease: Current evidence and future directions. Calsolaro V; Edison P Alzheimers Dement; 2016 Jun; 12(6):719-32. PubMed ID: 27179961 [TBL] [Abstract][Full Text] [Related]
3. Neuroinflammation and regeneration in the early stages of Alzheimer's disease pathology. Hoozemans JJ; Veerhuis R; Rozemuller JM; Eikelenboom P Int J Dev Neurosci; 2006; 24(2-3):157-65. PubMed ID: 16384684 [TBL] [Abstract][Full Text] [Related]
4. Systemic infection modifies the neuroinflammatory response in late stage Alzheimer's disease. Rakic S; Hung YMA; Smith M; So D; Tayler HM; Varney W; Wild J; Harris S; Holmes C; Love S; Stewart W; Nicoll JAR; Boche D Acta Neuropathol Commun; 2018 Sep; 6(1):88. PubMed ID: 30193587 [TBL] [Abstract][Full Text] [Related]
5. Exploiting microglial and peripheral immune cell crosstalk to treat Alzheimer's disease. Dionisio-Santos DA; Olschowka JA; O'Banion MK J Neuroinflammation; 2019 Apr; 16(1):74. PubMed ID: 30953557 [TBL] [Abstract][Full Text] [Related]
6. Anti-α4β1 Integrin Antibodies Attenuated Brain Inflammatory Changes in a Mouse Model of Alzheimer's Disease. Manocha G; Ghatak A; Puig K; Combs C Curr Alzheimer Res; 2018; 15(12):1123-1135. PubMed ID: 30068274 [TBL] [Abstract][Full Text] [Related]
7. A Path Toward Precision Medicine for Neuroinflammatory Mechanisms in Alzheimer's Disease. Hampel H; Caraci F; Cuello AC; Caruso G; Nisticò R; Corbo M; Baldacci F; Toschi N; Garaci F; Chiesa PA; Verdooner SR; Akman-Anderson L; Hernández F; Ávila J; Emanuele E; Valenzuela PL; Lucía A; Watling M; Imbimbo BP; Vergallo A; Lista S Front Immunol; 2020; 11():456. PubMed ID: 32296418 [TBL] [Abstract][Full Text] [Related]
8. Microdose Lithium NP03 Diminishes Pre-Plaque Oxidative Damage and Neuroinflammation in a Rat Model of Alzheimer's-like Amyloidosis. Wilson EN; Do Carmo S; Iulita MF; Hall H; Austin GL; Jia DT; Malcolm JC; Foret MK; Marks AR; Butterfield DA; Cuello AC Curr Alzheimer Res; 2018; 15(13):1220-1230. PubMed ID: 30182855 [TBL] [Abstract][Full Text] [Related]
9. Rodent models of neuroinflammation for Alzheimer's disease. Nazem A; Sankowski R; Bacher M; Al-Abed Y J Neuroinflammation; 2015 Apr; 12():74. PubMed ID: 25890375 [TBL] [Abstract][Full Text] [Related]
10. Microglia prevent peripheral immune cell invasion and promote an anti-inflammatory environment in the brain of APP-PS1 transgenic mice. Unger MS; Schernthaner P; Marschallinger J; Mrowetz H; Aigner L J Neuroinflammation; 2018 Sep; 15(1):274. PubMed ID: 30241479 [TBL] [Abstract][Full Text] [Related]
11. Alzheimer's disease: microglia targets and their modulation to promote amyloid phagocytosis and mitigate neuroinflammation. Anwar S; Rivest S Expert Opin Ther Targets; 2020 Apr; 24(4):331-344. PubMed ID: 32129117 [No Abstract] [Full Text] [Related]
12. Fibrillar Aβ triggers microglial proteome alterations and dysfunction in Alzheimer mouse models. Sebastian Monasor L; Müller SA; Colombo AV; Tanrioever G; König J; Roth S; Liesz A; Berghofer A; Piechotta A; Prestel M; Saito T; Saido TC; Herms J; Willem M; Haass C; Lichtenthaler SF; Tahirovic S Elife; 2020 Jun; 9():. PubMed ID: 32510331 [TBL] [Abstract][Full Text] [Related]
13. Vaccine-induced Aβ-specific CD8+ T cells do not trigger autoimmune neuroinflammation in a murine model of Alzheimer's disease. Rosset MB; Lui G; Dansokho C; Chaigneau T; Dorothée G J Neuroinflammation; 2015 May; 12():95. PubMed ID: 25982697 [TBL] [Abstract][Full Text] [Related]
15. Dihydromyricetin inhibits microglial activation and neuroinflammation by suppressing NLRP3 inflammasome activation in APP/PS1 transgenic mice. Feng J; Wang JX; Du YH; Liu Y; Zhang W; Chen JF; Liu YJ; Zheng M; Wang KJ; He GQ CNS Neurosci Ther; 2018 Dec; 24(12):1207-1218. PubMed ID: 29869390 [TBL] [Abstract][Full Text] [Related]
16. Untangling the Web: Toxic and Protective Effects of Neuroinflammation and PGE2 Signaling in Alzheimer's Disease. Woodling NS; Andreasson KI ACS Chem Neurosci; 2016 Apr; 7(4):454-63. PubMed ID: 26979823 [TBL] [Abstract][Full Text] [Related]
17. The role of neuroinflammation and amyloid in cognitive impairment in an APP/PS1 transgenic mouse model of Alzheimer's disease. Zhu S; Wang J; Zhang Y; He J; Kong J; Wang JF; Li XM CNS Neurosci Ther; 2017 Apr; 23(4):310-320. PubMed ID: 28191738 [TBL] [Abstract][Full Text] [Related]
18. The effect of focal brain injury on beta-amyloid plaque deposition, inflammation and synapses in the APP/PS1 mouse model of Alzheimer's disease. Collins JM; King AE; Woodhouse A; Kirkcaldie MT; Vickers JC Exp Neurol; 2015 May; 267():219-29. PubMed ID: 25747037 [TBL] [Abstract][Full Text] [Related]
19. The contribution of neuroinflammation to amyloid toxicity in Alzheimer's disease. Minter MR; Taylor JM; Crack PJ J Neurochem; 2016 Feb; 136(3):457-74. PubMed ID: 26509334 [TBL] [Abstract][Full Text] [Related]
20. Amylin Treatment Reduces Neuroinflammation and Ameliorates Abnormal Patterns of Gene Expression in the Cerebral Cortex of an Alzheimer's Disease Mouse Model. Wang E; Zhu H; Wang X; Gower AC; Wallack M; Blusztajn JK; Kowall N; Qiu WQ J Alzheimers Dis; 2017; 56(1):47-61. PubMed ID: 27911303 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]